Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3978100 | Brachytherapy | 2007 | 7 Pages |
Abstract
Previously identified factors of importance for urinary morbidity such as pretreatment prostate volume and baseline urinary function were reemphasized in this study. Regional urethral dosimetry within contemporary practice does not seem to influence the nature or extent of urinary symptoms after prostate brachytherapy. Consequently, region sparing dosimetric modifications are not warranted to alter symptomatic outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mischel Neill, Gabrielle Studer, Lisa Le, Michael McLean, Ivan Yeung, Greg Pond, Juanita M. Crook,